BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 6875299)

  • 1. [Histological follow-up after implantation of grains of I-125 for prostatic cancer].
    Nadalini VF; Giglio C; Bruttini G; Positano N; Fassone M; Fasce L; Medica M; de Angelis P; Fantacci O; Scarpati D; Ledda S
    J Urol (Paris); 1983; 89(3):187-190. PubMed ID: 6875299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Results of interstitial radiotherapy using I-125 seeds in the treatment of prostatic cancer].
    Rohloff R; Tauber R; Schätzl M; Wendt T; Willich N
    Strahlenther Onkol; 1988 Apr; 164(4):195-201. PubMed ID: 3363484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective assessment of patient-reported long-term urinary morbidity and associated quality of life changes after 125I prostate brachytherapy.
    Stone NN; Stock RG
    Brachytherapy; 2003; 2(1):32-9. PubMed ID: 15062161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxicity after three-dimensional radiotherapy for prostate cancer with RTOG 9406 dose level IV.
    Michalski JM; Winter K; Purdy JA; Perez CA; Ryu JK; Parliament MB; Valicenti RK; Roach M; Sandler HM; Markoe AM; Cox JD
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):735-42. PubMed ID: 14967428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modern prostate brachytherapy. Prostate specific antigen results in 219 patients with up to 12 years of observed follow-up.
    Ragde H; Korb LJ; Elgamal AA; Grado GL; Nadir BS
    Cancer; 2000 Jul; 89(1):135-41. PubMed ID: 10897010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Changes of edema associated with I-125 prostate brachytherapy].
    Aoki M; Miki K; Takahashi H; Takagi S; Fukuda I; Honda C; Kobayashi M; Egawa S; Kanehira C
    Nihon Igaku Hoshasen Gakkai Zasshi; 2005 Oct; 65(4):411-8. PubMed ID: 16334395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved biochemical relapse-free survival with increased external radiation doses in patients with localized prostate cancer: the combined experience of nine institutions in patients treated in 1994 and 1995.
    Kupelian P; Kuban D; Thames H; Levy L; Horwitz E; Martinez A; Michalski J; Pisansky T; Sandler H; Shipley W; Zelefsky M; Zietman A
    Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):415-9. PubMed ID: 15667961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PSA kinetics following I-125 radioactive seed implantation in the treatment of T1-T2 prostate cancer.
    Iannuzzi CM; Stock RG; Stone NN
    Radiat Oncol Investig; 1999; 7(1):30-5. PubMed ID: 10030621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cancer of the prostate: technics of curietherapy. Review of the literature and experience at the Institut Gustave-Roussy].
    Chassagne D; Court B; Gerbaulet A; Perrin JL; Haie C
    Bull Cancer; 1985; 72(6):578-84. PubMed ID: 4092108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perineural invasion is not predictive of biochemical outcome following prostate brachytherapy.
    Merrick GS; Butler WM; Galbreath RW; Lief JH; Adamovich E
    Cancer J; 2001; 7(5):404-12. PubMed ID: 11693899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Permanent interstitial brachytherapy in younger patients with clinically organ-confined prostate cancer.
    Merrick GS; Butler WM; Wallner KE; Galbreath RW; Adamovich E
    Urology; 2004 Oct; 64(4):754-9. PubMed ID: 15491715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-year results of treatment for prostate cancer with low-dose rate temporary iridium-192 brachytherapy.
    Momma T; Saito S; Toya K; Yorozu A; Dokiya T; Murai M
    Int J Urol; 2006 Mar; 13(3):218-23. PubMed ID: 16643612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Candidates for prostate radioactive seed implantation treated by external beam radiotherapy.
    Seung SK; Kroll S; Wilder RB; Posner MD; Roach M
    Cancer J Sci Am; 1998; 4(3):168-74. PubMed ID: 9612598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Percutaneous, perineal, ultrasound-controlled implantation of 125iodine in prostatic cancer: technics, report of initial experiences and comparison with the retropubic method of implantation].
    Riccabona M; Hammer J; Schorn A
    Urologe A; 1987 Jan; 26(1):15-21. PubMed ID: 3554696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination external beam radiation and brachytherapy boost with androgen suppression for treatment of intermediate-risk prostate cancer: an initial report of CALGB 99809.
    Hurwitz MD; Halabi S; Ou SS; McGinnis LS; Keuttel MR; Dibiase SJ; Small EJ
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):814-9. PubMed ID: 18407435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical results of combined treatment conformal high-dose-rate iridium-192 brachytherapy and external beam radiotherapy using staging lymphadenectomy for localized prostate cancer.
    Hiratsuka J; Jo Y; Yoshida K; Nagase N; Fujisawa M; Imajo Y
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):684-90. PubMed ID: 15183471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiation dose predicts for biochemical control in intermediate-risk prostate cancer patients treated with low-dose-rate brachytherapy.
    Ho AY; Burri RJ; Cesaretti JA; Stone NN; Stock RG
    Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):16-22. PubMed ID: 19289266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined brachytherapy with external beam radiotherapy for localized prostate cancer: reduced morbidity with an intraoperative brachytherapy planning technique and supplemental intensity-modulated radiation therapy.
    Zelefsky MJ; Nedelka MA; Arican ZL; Yamada Y; Cohen GN; Shippy AM; Park JJ; Zaider M
    Brachytherapy; 2008; 7(1):1-6. PubMed ID: 18299108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preimplant predictive factors of urinary retention after iodine 125 prostate brachytherapy.
    Mabjeesh NJ; Chen J; Stenger A; Matzkin H
    Urology; 2007 Sep; 70(3):548-53. PubMed ID: 17905113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.